辉瑞制药Pfizer-201404-AACRAnaystBriefingDeck

1AACR2014AnalystBriefingApril6,20142ForwardLookingStatements?Ourdiscussionsduringthismeetingwillincludeforward-lookingstatements.Actualresultscoulddiffermateriallyfromthoseprojectedintheforward-lookingstatements.?ThefactorsthatcouldcauseactualresultstodifferarediscussedinPfizer’s2013AnnualReportonForm10-K,inourreportsonForm10-QandForm8-KandinthepressreleaseconcerningthePALOMA-1trialthatwasissuedtoday.?OurSECreportsandpressreleasesareavailableonourwebsiteatwww.pfizer.com.http://www.pfizer.com/3GarryNicholsonPresidentPfizerOncology4PfizerOncologyMission:ToCureandControlCancerwithInnovativeMedicinesPfizerOncology:FocusedExecutionGrowsFranchisePhase3PipelinePhase1/2PipelineHighlightsPF04449913SMOinhibitorPF06463922ALK/ROS1InhibitorPF050825664-1BBPF03084014Gamma